CHAPTER 1. INTRODUCTION
1.1.Market Definition
1.2.Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2.Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5.Degree of Competition
3.3.PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Increasing R&D in the field of proteomics and genomics
4.1.2. High prevalence of infectious diseases
4.1.3. Rapid growth in biopharmaceutical & biotechnology companies
4.1.4. Rising focus on personalised medicine
4.1.5. Increasing government funding for cell-based research
4.2. Market Restraints & Challenges
4.2.1. The high cost of cell-based research
4.2.2. Lack of skilled professionals
4.2.3. Survival of small players and new entrants
4.3. Market Opportunities
4.3.1. Emerging countries
CHAPTER 5. GLOBAL CELL LYSIS MARKET– BY PRODUCT
5.1. Instruments
5.1.1. Sonicators
5.1.2. Homogenizers
5.1.3. Others
5.2. Consumables
5.2.1. Reagents & Kits
5.2.1.1. Enzymes
5.2.1.2. Detergent Solutions
5.2.1.3. Others
5.2.2. Beads
5.2.3. Disposables
CHAPTER 6. GLOBAL CELL LYSIS MARKET – BY CELL TYPE
6.1. Mammalian Cells
6.2. Microbial Cells
6.3. Others
CHAPTER 7. GLOBAL CELL LYSIS MARKET – BY END USER
7.1. Biopharmaceutical & Biotechnology Companies
7.2. Research Laboratories and Institutes
7.3. Others
CHAPTER 8. GLOBAL CELL LYSIS MARKET - BY GEOGRAPHY
8.1. Introduction
8.2.North America
8.2.1. The U.S.
8.2.2. Canada
8.2.3. Mexico
8.2.4. Costa Rica
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Chile
8.3.4. Columbia
8.3.5. Others
8.4. Europe
8.4.1. U.K.
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Russia
8.4.7. Netherlands
8.4.8. Switzerland
8.4.9. Poland
8.4.10. Others
8.5. APAC
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. South Korea
8.5.5. Australia & New Zealand
8.5.6. Malaysia
8.5.7. Singapore
8.5.8. Others
8.6. Middle East & Africa
8.6.1. UAE
8.6.2. Saudi Arabia
8.6.3. Iran
8.6.4. Iraq
8.6.5. Qatar
8.6.6. South Africa
8.6.7. Algeria
8.6.8. Morocco
8.6.9. Nigeria
8.6.10. Egypt
8.6.11. Others
CHAPTER 9. GLOBAL CELL LYSIS MARKET - COMPANY PROFILES
9.1. Merck KGaA
9.2. Beckton, Dickinson and Company
9.3. Roche Diagnostics
9.4. Cell Signaling Technology, Inc.
9.5. Thermo Fisher Scientific
9.6. Bio-Rad Laboratories, Inc.
9.7. QIAGEN N.V.
9.8. Takara Bio, Inc.
9.9. Qsonica, LLC
9.10. Labfreez Instruments Group Co., Ltd
9.11. Eppendorf AG
9.12. MiltenyiBiotec
9.13. Beckman Coulter, Inc.
9.14. Merck Millipore
CHAPTER 10. GLOBAL CELL LYSIS MARKET - COMPETITIVE LANDSCAPE
10.1. Market Share Analysis
10.2. Strategies adopted by top companies
10.3.Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 11. MARKET INSIGHTS
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
CHAPTER 12. APPENDIX
12.1. List of Tables
12.2. List of Figures
